АЛЬКАРА, Лилиан (IT),ПАНЧАЛ, Терри Аарон (IT),ДЖЕННИНГЗ, Эндрю Стефен Роберт (IT),КРИДЛЭНД, Эндрю Питер (IT),ХАРЛИ, Кристофер (IT)
申请号：
RU2015151823
公开号：
RU2015151823A
申请日:
2013.06.06
申请国别(地区):
RU
年份:
2017
代理人:
摘要：
Mitogen activated protein kinase (MAPK) inhibitors disclosed herein are useful for the treatment of diseases of the respiratory tract, such as chronic eosinophilic pneumonia, asthma, COPD, adult respiratory distress syndrome (ARDS), exacerbation of airways hyper-reactivity consequent to other drug therapy, and airways disease that is associated with pulmonary hypertension.
